BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, Hydrochloride], a Nonimidazole Inverse Agonist/Antagonist at the Human Histamine H3 Receptor: Preclinical Pharmacology
Xavier Ligneau, David Perrin, Laurent Landais et al. · Journal of Pharmacology and Experimental Therapeutics · 2006
Cited by 237 works. doi:10.1124/jpet.106.111039
Authors
- Xavier Ligneau
- David Perrin
- Laurent Landais
- J.-C. Camelin
- Thierry Calmels
- Isabelle Berrebi‐Bertrand
- J Lecomte
- Régis Parmentier
- Christelle Anaclet
- Jian‐Sheng Lin
- Valérie Bertaina‐Anglade
- Christophe Drieu La Rochelle
- Fabiana D'Aniello
- Agnès Rouleau
- Florence Gbahou
- Jean‐Michel Arrang
- C. Robin Ganellin
- Holger Stark
- Walter G. Schunack
- Jean‐Charles Schwartz
References
- The Rat Brain in Stereotaxic Coordinates
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
- International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
- PHARMACOLOGICAL ESTIMATION OF DRUG-RECEPTOR DISSOCIATION CONSTANTS. STATISTICAL EVALUATION. I. AGONISTS
- Highly potent and selective ligands for histamine H3-receptors
- Histaminergic transmission in the mammalian brain
- Neuropsychopharmacology : The Fifth Generation of Progress
- International Union of Pharmacology. XIII. Classification of Histamine Receptors
- Cloning and Functional Expression of the Human Histamine H3Receptor
- G Protein-Coupled Receptor Allosterism and Complexing